These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1225753)

  • 1. [Isolation and properties of several auxotrophic mutants of a highly virulent strain of the plague microbe].
    Martinevskiĭ IL
    Genetika; 1975; 11(2):140-4. PubMed ID: 1225753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation and properties of several auxotrophic mutants of a highly virulent strain of the plague microbe].
    Martinevskiĭ IL
    Genetika; 1975; 11(2):140-4. PubMed ID: 1232031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proline-dependent wild strains and proline-dependent mutants of the plague microbe].
    Martinevskiĭ IL
    Genetika; 1979 Dec; 15(12):2134-9. PubMed ID: 159850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nitrosoguanidine induction of mutants in Salmonella cholerae suis].
    Todorov T; Stoianov V; Ganovski D; Koleva P; Stoev I
    Vet Med Nauki; 1978; 15(8):61-6. PubMed ID: 751321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Occurrence of induced vitamin-dependent mutants of Yersinia pestis].
    Khozova NA; Suchkov IuG
    Genetika; 1977; 13(11):2053-5. PubMed ID: 614956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transport of basic amino acids into Yersinia pestis cells].
    Naumov AV; Borisova NP
    Mol Gen Mikrobiol Virusol; 1987 Mar; (3):38-42. PubMed ID: 3106795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of PGM mutation mechanism in Yersinia pestis (plague pathogen) vaccine strain EV76].
    Podladchikova ON; Rykova VA; Ivanova VS; Eremenko NS; Lebedeva SA
    Mol Gen Mikrobiol Virusol; 2002; (2):14-9. PubMed ID: 12180018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the antibody neutralization reaction in differential diagnosis of the etiologic agent of plague and the study of mutual relations between the amount of fraction I and virulence in strains of the plague microbe (Pasteurella pestis).
    Timofeeva LA; Aparin GP
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(4):420-5. PubMed ID: 5752128
    [No Abstract]   [Full Text] [Related]  

  • 9. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
    Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
    Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A gene expression study and the isolation and immunobiological properties of the iron-regulated membrane proteins of the plague microbe].
    Ledvanov MIu; Carniel E; Tikhonov SN; Popov IuA; Kulichenko AN; Kireev MN; Korovkin SA; Stukova NIu; Lotsmanova EIu; Anisimova VA
    Med Parazitol (Mosk); 1995; (4):23-6. PubMed ID: 8587512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Iron assimilation by Yersinia pestis on iron-deficient media].
    Rublev BD; Kagramanov VS; Bursha OS; Ryzhkov VIu
    Mikrobiol Zh (1978); 1989; 51(1):13-8. PubMed ID: 2524638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolation of auxotrophic mutants of Rhodopseudomonas sphaeroides].
    Muronets EM
    Mikrobiologiia; 1982; 51(5):871-3. PubMed ID: 6757682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The isolation and characteristics of variant plague microbes not producing the capsular antigen].
    Gvozdenko NA; Ryzhkov VIu; Pavlovich NV
    Mikrobiol Zh (1978); 1990; 52(6):13-7. PubMed ID: 2097497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuftsin-like activity of amino acids.
    Slopek S; Steuden W; Kaczmarek M
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):915-7. PubMed ID: 6678146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased virulence of Yersinia pseudotuberculosis by two independent mutations.
    Rosqvist R; Skurnik M; Wolf-Watz H
    Nature; 1988 Aug; 334(6182):522-4. PubMed ID: 3043229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of defined F1 negative mutants of virulent Yersinia pestis.
    Worsham PL; Stein MP; Welkos SL
    Contrib Microbiol Immunol; 1995; 13():325-8. PubMed ID: 8833864
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of vitamin C depletion on the free amino acid content in blood plasma of the guinea pig.
    Hornig D; Weber F; Wiss O
    Int J Vitam Nutr Res; 1971; 41(1):86-9. PubMed ID: 5125379
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain C092.
    Welkos SL; Friedlander AM; Davis KJ
    Microb Pathog; 1997 Oct; 23(4):211-23. PubMed ID: 9344782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague.
    Swietnicki W; Powell BS; Goodin J
    Protein Expr Purif; 2005 Jul; 42(1):166-72. PubMed ID: 15939303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.